OBS Immunology and Cancer Seminar: CD8+ T cells in cancer and immunotherapy
*Paper reference: CD8+ T cell activation in cancer comprises an initial activation phase in lymph nodes followed by effector differentiation within the tumor (Immunity 2022)
*Speaker: Nataliya Prokhnevska (Past affiliation: Emory University. Current affiliation: Memorial Sloan Kettering Cancer Center)